Responsibility for ancillary care in clinical trials: Research patrimony and unintended coercion are hazardsBMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7459.232-c (Published 22 July 2004) Cite this as: BMJ 2004;329:232
- Arvindan Veiraiah (firstname.lastname@example.org), research registrar in cardiology
- Royal Sussex County Hospital, Brighton BN2 1ES
EDITOR—I agree with many of the assessments and suggestions made by Belsky and Richardson on medical researchers' responsibilities for ancillary care,1 but important issues remain to be considered.
The need to explore ancillary care is just as important in developed countries as it is in developing countries. British study participants, for example, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial